China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 10.6% in First Three Quarters of 2022

China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 1 billion yuan in the first three quarters of 2022, up 10.6% year-on-year.

Meanwhile, the company posted 7.2 billion yuan in revenue, up 4.1% year-on-year.

At the end of the reporting period, it had 14.6 billion yuan in total assets and 4.1 billion yuan in total liabilities, with a liability-to-asset ratio of 28.1%.